{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T09:16:36Z","timestamp":1794647796971,"version":"4.9.1"},"reference-count":160,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T00:00:00Z","timestamp":1578873600000},"content-version":"vor","delay-in-days":5643,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpsmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pain and Symptom Management"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1016\/j.jpainsymman.2004.05.002","type":"journal-article","created":{"date-parts":[[2004,7,24]],"date-time":"2004-07-24T10:25:55Z","timestamp":1090664755000},"page":"140-175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":305,"title":["Comparative efficacy and safety of skeletal muscle relaxants for spasticity and musculoskeletal conditions: a systematic review"],"prefix":"10.1016","volume":"28","author":[{"given":"Roger","family":"Chou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Helfand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11 Suppl 9","key":"10.1016\/j.jpainsymman.2004.05.002_BIB1","first-page":"S12","article-title":"Spasticity: a review","volume":"44","author":"Young","year":"1994","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.jpainsymman.2004.05.002_BIB2","first-page":"313","article-title":"Current pharmacologic treatment of multiple sclerosis symptoms","volume":"165","author":"Andersson","year":"1996","journal-title":"West J Med"},{"issue":"24 Suppl","key":"10.1016\/j.jpainsymman.2004.05.002_BIB3","doi-asserted-by":"crossref","first-page":"S146","DOI":"10.1097\/00007632-200112151-00024","article-title":"Pain and spasticity after spinal cord injury: mechanisms and treatment","volume":"26","author":"Burchiel","year":"2001","journal-title":"Spine"},{"issue":"Suppl. 1","key":"10.1016\/j.jpainsymman.2004.05.002_BIB4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/ageing\/30.suppl_1.13","article-title":"Medical management of spasticity in stroke","volume":"30","author":"Barnes","year":"2001","journal-title":"Age Ageing"},{"issue":"8678-8679","key":"10.1016\/j.jpainsymman.2004.05.002_BIB5","first-page":"1488","article-title":"Spasticity","volume":"2","author":"Anonymous","year":"1989","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.jpainsymman.2004.05.002_BIB6","doi-asserted-by":"crossref","first-page":"850","DOI":"10.7326\/0003-4819-131-11-199912070-00009","article-title":"Management of fibromyalgia","volume":"131","author":"Leventhal","year":"1999","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.jpainsymman.2004.05.002_BIB7","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1046\/j.1526-4610.2000.00014.x","article-title":"Prophylactic pharmacological treatment of chronic daily headache","volume":"40","author":"Redillas","year":"2000","journal-title":"Headache"},{"issue":"24","key":"10.1016\/j.jpainsymman.2004.05.002_BIB8","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1097\/00007632-199612150-00007","article-title":"Drug therapy for back pain: Which drugs help which patients?","volume":"21","author":"Deyo","year":"1996","journal-title":"Spine"},{"issue":"2","key":"10.1016\/j.jpainsymman.2004.05.002_BIB9","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1176\/appi.psy.41.2.104","article-title":"Antidepressant treatment of fibromyalgia. A meta-analysis and review","volume":"41","author":"Arnold","year":"2000","journal-title":"Psychosomatics"},{"issue":"5","key":"10.1016\/j.jpainsymman.2004.05.002_BIB10","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/00007632-199803010-00015","article-title":"Medication use for low back pain in primary care","volume":"23","author":"Cherkin","year":"1998","journal-title":"Spine"},{"issue":"1","key":"10.1016\/j.jpainsymman.2004.05.002_BIB11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003495-197408010-00001","article-title":"Baclofen: a preliminary report of its pharmacological properties and therapeutic efficacy in spasticity","volume":"8","author":"Brogden","year":"1974","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.jpainsymman.2004.05.002_BIB12","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/ana.410170202","article-title":"Antispasticity drugs: mechanisms of action","volume":"17","author":"Davidoff","year":"1985","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.jpainsymman.2004.05.002_BIB13","doi-asserted-by":"crossref","first-page":"435","DOI":"10.2165\/00003495-199753030-00007","article-title":"Tizanidine. A review of its pharmacology, clinical efficacy and tolerability in the management of spasticity associated with cerebral and spinal disorders","volume":"53","author":"Wagstaff","year":"1997","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.jpainsymman.2004.05.002_BIB14","first-page":"11","article-title":"Tizanidine: An \u03b12-agonist imidazoline with antispasticity effects","volume":"15","author":"Nance","year":"1997","journal-title":"Today's Ther Trends"},{"issue":"3","key":"10.1016\/j.jpainsymman.2004.05.002_BIB15","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2165\/00003495-200059030-00006","article-title":"Drugs used to treat spasticity","volume":"59","author":"Kita","year":"2000","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.jpainsymman.2004.05.002_BIB16","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0022-510X(67)90005-6","article-title":"On the site of action of diazepam in spasticity in man","volume":"5","author":"Cook","year":"1967","journal-title":"J Neurol Sci"},{"issue":"9 Pt 2","key":"10.1016\/j.jpainsymman.2004.05.002_BIB17","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1212\/WNL.28.9_Part_2.46","article-title":"Pharmacology of spasticity","volume":"28","author":"Davidoff","year":"1978","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.jpainsymman.2004.05.002_BIB18","first-page":"1","article-title":"A double-blind, multicenter trial of methocarbamol (Robaxin\u2122) and cyclobenzaprine (Flexeril(TM)) in acute musculoskeletal conditions","volume":"1","author":"Preston","year":"1984","journal-title":"Today's Ther Trends"},{"issue":"2","key":"10.1016\/j.jpainsymman.2004.05.002_BIB19","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1300\/J069v18n02_05","article-title":"Carisoprodol (soma): abuse potential and physician unawareness","volume":"18","author":"Reeves","year":"1999","journal-title":"J Addict Dis"},{"key":"10.1016\/j.jpainsymman.2004.05.002_BIB20","first-page":"189","article-title":"Double-blind study of Parafon Forte and Flexeril in the treatment of acute skeletal muscle disorders","volume":"26","author":"Azoury","year":"1979","journal-title":"Curr Ther Res"},{"issue":"6","key":"10.1016\/j.jpainsymman.2004.05.002_BIB21","first-page":"451","article-title":"Orphenadrine citrate: Sedative or muscle relaxant?","volume":"1","author":"Gold","year":"1978","journal-title":"Clin Ther"},{"issue":"1","key":"10.1016\/j.jpainsymman.2004.05.002_BIB22","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1177\/104990910001700111","article-title":"Tizanidine in the management of spasticity and musculoskeletal complaints in the palliative care population","volume":"17","author":"Smith","year":"2000","journal-title":"Am J Hosp Palliat Care"},{"issue":"2","key":"10.1016\/j.jpainsymman.2004.05.002_BIB23","first-page":"164","article-title":"A double-blind study of Parafon Forte\u2122 and Flexeril(TM) in the treatment of acute skeletal muscle disorders of local origin","volume":"28","author":"McMillen","year":"1980","journal-title":"Curr Ther Res"},{"issue":"4","key":"10.1016\/j.jpainsymman.2004.05.002_BIB24","first-page":"444","article-title":"A comparative study of Parafon Forte tablets and Soma compund in the treatment of painful skeletal muscle conditions","volume":"19","author":"Miller","year":"1976","journal-title":"Curr Ther Res Clin Exp"},{"issue":"5","key":"10.1016\/j.jpainsymman.2004.05.002_BIB25","first-page":"666","article-title":"Parafon Forte versus Robaxisal in skeletal muscle disorders: a double-blind study","volume":"20","author":"Gready","year":"1976","journal-title":"Curr Ther Res Clin Exp"},{"issue":"5","key":"10.1016\/j.jpainsymman.2004.05.002_BIB26","first-page":"248","article-title":"Value of an acetaminophen-chlorzoxazone combination (Parafon Forte) in the treatment of acute musculoskeletal disorders","volume":"15","author":"Walker","year":"1973","journal-title":"Curr Ther Res, Clin Exp"},{"issue":"12","key":"10.1016\/j.jpainsymman.2004.05.002_BIB27","first-page":"801","article-title":"A double-blind evaluation of Parafon Forte in the treatment of musculo-skeletal back conditions","volume":"14","author":"Vernon","year":"1972","journal-title":"Curr Ther Res, Clin Exp"},{"issue":"3","key":"10.1016\/j.jpainsymman.2004.05.002_BIB28","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1742-1241.1984.tb07263.x","article-title":"A comparison of two analgesic muscle relaxant combinations in acute back pain","volume":"38","author":"Middleton","year":"1984","journal-title":"Br J Clin Pract"},{"issue":"2","key":"10.1016\/j.jpainsymman.2004.05.002_BIB29","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1177\/030006059302100202","article-title":"A double-blind crossover study of two cyclobenzaprine regimens in primary fibromyalgia syndrome","volume":"21","author":"Santandrea","year":"1993","journal-title":"J Int Med Res"},{"key":"10.1016\/j.jpainsymman.2004.05.002_BIB30","first-page":"540","article-title":"Preliminary trial of carisoprodol in multiple sclerosis","volume":"192","author":"Ashworth","year":"1964","journal-title":"Practitioner"},{"key":"10.1016\/j.jpainsymman.2004.05.002_BIB31","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/ptj\/67.2.206","article-title":"Inter rater reliability of a modified Ashworth Scale of muscle spasticity","volume":"67","author":"Bohannon","year":"1987","journal-title":"Phys Ther"},{"key":"10.1016\/j.jpainsymman.2004.05.002_BIB32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0022-510X(95)00261-Y","article-title":"Clinical scales for multiple sclerosis","volume":"135","author":"Sharrack","year":"1996","journal-title":"J Neurol Sci"},{"issue":"10","key":"10.1016\/j.jpainsymman.2004.05.002_BIB33","first-page":"1558","article-title":"Development of preliminary criteria for response to treatment in fibromyalgia syndrome","volume":"18","author":"Simms","year":"1991","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.jpainsymman.2004.05.002_BIB34","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3109\/03009749709065657","article-title":"Assessment of functional limitation and disability in patients with fibromyalgia","volume":"26","author":"Mannerkorpi","year":"1997","journal-title":"Scand J Rheumatol"},{"issue":"9","key":"10.1016\/j.jpainsymman.2004.05.002_BIB35","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1212\/WNL.40.9.1427","article-title":"Dantrolene sodium and hepatic injury","volume":"40","author":"Chan","year":"1990","journal-title":"Neurol"},{"issue":"3","key":"10.1016\/j.jpainsymman.2004.05.002_BIB36","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1600-0404.1987.tb07916.x","article-title":"The treatment of spasticity in multiple sclerosis: a double-blind clinical trial of a new anti-spastic drug tizanidine compared with baclofen","volume":"75","author":"Stien","year":"1987","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.jpainsymman.2004.05.002_BIB37","unstructured":"Anonymous. 2003. Methods for drug class reviews for Oregon Health Plan Practitioner-Managed Prescription Drug Plan. Oregon Evidence-based Practice Center, Portland, OR. Available at: http:\/\/www.oregonrx.org\/OrgrxPDF\/Skeletal%20Muscle% 20Relaxants\/Revised%20EPC%20Reprt%204-9-03\/ App%20C%20OHP%20Methods%202003.pdf."},{"issue":"3S","key":"10.1016\/j.jpainsymman.2004.05.002_BIB38","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0749-3797(01)00261-6","article-title":"Current methods of the third U.S. Preventive Services Task Force","volume":"20","author":"Harris","year":"2001","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.jpainsymman.2004.05.002_BIB39","series-title":"Undertaking systematic reviews of research on effectiveness: CRD's guidance for those carrying out or commissioning reviews CRD Report Number 4","author":"Anonymous","year":"2001"},{"key":"10.1016\/j.jpainsymman.2004.05.002_BIB40","unstructured":"Mulrow CD, Oxman A. How to conduct a Cochrane systematic review. Version 3.0.2."},{"issue":"4","key":"10.1016\/j.jpainsymman.2004.05.002_BIB41","first-page":"CD001332","article-title":"Anti-spasticity agents for multiple sclerosis","author":"Shakespeare","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"13","key":"10.1016\/j.jpainsymman.2004.05.002_BIB42","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1001\/archinte.161.13.1613","article-title":"Cyclobenzaprine and back pain: a meta-analysis","volume":"161","author":"Browning","year":"2001","journal-title":"Arch Intern Med"},{"issue":"11 Suppl 9","key":"10.1016\/j.jpainsymman.2004.05.002_BIB43","first-page":"S53","article-title":"Comparative profile of tizanidine in the management of spasticity","volume":"44","author":"Lataste","year":"1994","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.jpainsymman.2004.05.002_BIB44","first-page":"CD001131","article-title":"Pharmacological interventions for spasticity following spinal cord injury","author":"Taricco","year":"2000","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11 Suppl 9","key":"10.1016\/j.jpainsymman.2004.05.002_BIB45","first-page":"S60","article-title":"Summary of combined clinical analysis of controlled clinical trials with tizanidine","volume":"44","author":"Wallace","year":"1994","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.jpainsymman.2004.05.002_BIB46","first-page":"241","article-title":"Tizanidine treatment of spasticity: a meta-analysis of controlled, double-blind, comparative studies with baclofen and diazepam","volume":"15","author":"Groves","year":"1998","journal-title":"Adv Ther"},{"issue":"6","key":"10.1016\/j.jpainsymman.2004.05.002_BIB47","first-page":"409","article-title":"Cyclobenzaprine, diazepam and placebo in the treatment of skeletal muscle spasm of local origin","volume":"1","author":"Nibbelink","year":"1978","journal-title":"Clin Ther"},{"issue":"5","key":"10.1016\/j.jpainsymman.2004.05.002_BIB48","first-page":"304","article-title":"Medical treatment for spasticity in children with cerebral palsy","volume":"2","author":"Nogen","year":"1976","journal-title":"Child Brain"},{"issue":"10","key":"10.1016\/j.jpainsymman.2004.05.002_BIB49","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1185\/03007998809111122","article-title":"A multi-center, double-blind trial of tizanidine, a new antispastic agent, in spasticity associated with hemiplegia","volume":"10","author":"Bes","year":"1988","journal-title":"Curr Med Res Opin"},{"issue":"3","key":"10.1016\/j.jpainsymman.2004.05.002_BIB50","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1080\/01952307.1994.11735927","article-title":"A comparison of clonidine, cyproheptadine and baclofen in spastic spinal cord injured patients","volume":"17","author":"Nance","year":"1994","journal-title":"J Am Paraplegia Soc"},{"issue":"6","key":"10.1016\/j.jpainsymman.2004.05.002_BIB51","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1185\/03007998909110141","article-title":"A double-blind, long-term study of tizanidine (\u2018Sirdalud\u2019) in spasticity due to cerebrovascular lesions","volume":"11","author":"Medici","year":"1989","journal-title":"Curr Med Res Opin"},{"issue":"5","key":"10.1016\/j.jpainsymman.2004.05.002_BIB52","first-page":"278","article-title":"Baclofen versus diazepam for the treatment of spasticity and long-term follow-up of baclofen therapy","volume":"4","author":"Roussan","year":"1985","journal-title":"Pharmatherapeutica"},{"issue":"6 I","key":"10.1016\/j.jpainsymman.2004.05.002_BIB53","first-page":"827","article-title":"Tizanidine treatment of spasticity in multiple sclerosis and chronic myelopathy","volume":"28","author":"Rinne","year":"1980","journal-title":"Curr Ther Res Clin Exp"},{"issue":"3","key":"10.1016\/j.jpainsymman.2004.05.002_BIB54","first-page":"170","article-title":"A comparison of dantrolene sodium and diazepam in the treatment of spasticity","volume":"12","author":"Glass","year":"1974","journal-title":"Paraplegia"},{"issue":"11 Suppl 9","key":"10.1016\/j.jpainsymman.2004.05.002_BIB55","first-page":"S44","article-title":"Efficacy and safety of tizanidine in the treatment of spasticity in patients with spinal cord injury. North American Tizanidine Study Group","volume":"44","author":"Nance","year":"1994","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.jpainsymman.2004.05.002_BIB56","first-page":"374","article-title":"A double-blind comparative trial of new muscle relaxant, tizanidine (DS 103-282), and baclofen in the treatment of chronic spasticity in multiple sclerosis","volume":"7","author":"Smolenski","year":"1981","journal-title":"Curr Med Res Opin"},{"issue":"3","key":"10.1016\/j.jpainsymman.2004.05.002_BIB57","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1600-0404.1988.tb05899.x","article-title":"Tizanidine versus baclofen in the treatment of spasticity in multiple sclerosis patients","volume":"77","author":"Hoogstraten","year":"1988","journal-title":"Acta Neurol Scand"},{"issue":"10","key":"10.1016\/j.jpainsymman.2004.05.002_BIB58","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1185\/03007998809111121","article-title":"Multi-centre, double-blind trial of a novel antispastic agent, tizanidine, in spasticity associated with multiple sclerosis","volume":"10","author":"Eyssette","year":"1988","journal-title":"Curr Med Res Opin"},{"issue":"1","key":"10.1016\/j.jpainsymman.2004.05.002_BIB59","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/BF01061374","article-title":"Tizanidine in the treatment of spasticity","volume":"23","author":"Newman","year":"1982","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.jpainsymman.2004.05.002_BIB60","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1017\/S0317167100027104","article-title":"Tizanidine versus baclofen in the treatment of spasticity in patients with multiple sclerosis","volume":"15","author":"Bass","year":"1988","journal-title":"Can J Neurol Sci"},{"issue":"2","key":"10.1016\/j.jpainsymman.2004.05.002_BIB61","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1600-0404.1975.tb01366.x","article-title":"A double-blind trial with baclofen (Lioresal) and diazepam in spasticity due to multiple sclerosis","volume":"51","author":"From","year":"1975","journal-title":"Acta Neurol Scand"},{"issue":"4","key":"10.1016\/j.jpainsymman.2004.05.002_BIB62","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1136\/jnnp.39.4.350","article-title":"Comparison of dantrolene sodium and diazepam in the treatment of spasticity","volume":"39","author":"Schmidt","year":"1976","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.1016\/j.jpainsymman.2004.05.002_BIB63","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0022-510X(74)90137-3","article-title":"A comparison of baclofen and diazepam in the treatment of spasticity","volume":"23","author":"Cartlidge","year":"1974","journal-title":"J Neurol Sci"},{"issue":"5","key":"10.1016\/j.jpainsymman.2004.05.002_BIB64","first-page":"223","article-title":"Effects of a GABA-derivative (BA-34647) on spasticity. Preliminary report of a double-blind cross-over study","volume":"53","author":"Basmajian","year":"1974","journal-title":"Am J Phys Med"},{"issue":"4","key":"10.1016\/j.jpainsymman.2004.05.002_BIB65","first-page":"175","article-title":"Lioresal (baclofen) treatment of spasticity in multiple sclerosis","volume":"54","author":"Basmajian","year":"1975","journal-title":"Am J Phys Med"},{"issue":"3","key":"10.1016\/j.jpainsymman.2004.05.002_BIB66","first-page":"186","article-title":"Evaluation of treatment protocols on minimal to moderate spasticity in multiple sclerosis","volume":"72","author":"Brar","year":"1991","journal-title":"Arch Phys Med Rehab"},{"issue":"5","key":"10.1016\/j.jpainsymman.2004.05.002_BIB67","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1212\/WNL.26.5.441","article-title":"An evaluation of baclofen treatment for certain symptoms in patients with spinal cord lesions. A double-blind, cross-over study","volume":"26","author":"Duncan","year":"1976","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.jpainsymman.2004.05.002_BIB68","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1212\/WNL.28.11.1094","article-title":"Baclofen for spasticity in multiple sclerosis. Double blind crossover and three year study","volume":"28","author":"Feldman","year":"1978","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.jpainsymman.2004.05.002_BIB69","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/00002060-199010000-00006","article-title":"The supraspinal anxiolytic effect of baclofen for spasticity reduction","volume":"69","author":"Hinderer","year":"1990","journal-title":"Am J Phys Med Rehabil"},{"issue":"4","key":"10.1016\/j.jpainsymman.2004.05.002_BIB70","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/BF00613463","article-title":"Baclofen in the elderly stroke patient its side-effects and pharmacokinetics","volume":"29","author":"Hulme","year":"1985","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.jpainsymman.2004.05.002_BIB71","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/ageing\/12.2.155","article-title":"A double-blind comparison of quinine sulphate and placebo in muscle cramps","volume":"12","author":"Jones","year":"1983","journal-title":"Age Ageing"},{"issue":"SYMP","key":"10.1016\/j.jpainsymman.2004.05.002_BIB72","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1177\/003693308002500440","article-title":"Baclofen: A team approach to drug evaluation of spasticity in childhood","volume":"25","author":"McKinlay","year":"1980","journal-title":"Scott Med J"},{"issue":"4","key":"10.1016\/j.jpainsymman.2004.05.002_BIB73","first-page":"323","article-title":"Treatment of spasticity due to stroke. A double-blind, cross-over trial comparing baclofen with placebo","volume":"17","author":"Medaer","year":"1991","journal-title":"Acta Ther"},{"issue":"6","key":"10.1016\/j.jpainsymman.2004.05.002_BIB74","first-page":"398","article-title":"A controlled trial of baclofen in children with cerebral palsy","volume":"5","author":"Milla","year":"1977","journal-title":"J Int Med Res"},{"issue":"8","key":"10.1016\/j.jpainsymman.2004.05.002_BIB75","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/S1388-2457(00)00352-7","article-title":"The effect of baclofen on the transmission in spinal pathways in spastic multiple sclerosis patients","volume":"111","author":"Orsnes","year":"2000","journal-title":"Clin Neurophysiol"},{"issue":"7","key":"10.1016\/j.jpainsymman.2004.05.002_BIB76","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1001\/archneur.1977.00500190056008","article-title":"Baclofen, a new antispastic drug. A controlled, multicenter trial in patients with multiple sclerosis","volume":"34","author":"Sachais","year":"1977","journal-title":"Arch Neurol"},{"issue":"3","key":"10.1016\/j.jpainsymman.2004.05.002_BIB77","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1017\/S0317167100023994","article-title":"The use of baclofen in treatment of spasticity in multiple sclerosis","volume":"6","author":"Sawa","year":"1979","journal-title":"Can J Neurol Sci"},{"issue":"2","key":"10.1016\/j.jpainsymman.2004.05.002_BIB78","first-page":"61","article-title":"Dantrolene sodium in the treatment of spasticity","volume":"54","author":"Basmajian","year":"1973","journal-title":"Arch Phys Med Rehab"},{"issue":"8","key":"10.1016\/j.jpainsymman.2004.05.002_BIB79","first-page":"365","article-title":"Dantrolene sodium in athetoid cerebral palsy","volume":"54","author":"Chyatte","year":"1973","journal-title":"Arch Phys Med Rehab"},{"issue":"6","key":"10.1016\/j.jpainsymman.2004.05.002_BIB80","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1469-8749.1975.tb04697.x","article-title":"Treatment of spastic cerebral palsied children with sodium dantrolene","volume":"17","author":"Denhoff","year":"1975","journal-title":"Dev Med Child Neurol"},{"issue":"5","key":"10.1016\/j.jpainsymman.2004.05.002_BIB81","first-page":"835","article-title":"Dantrolene sodium in the treatment of spasticity caused by multiple sclerosis or degenerative myelopathies: A double-blind, cross-over study in comparison with placebo","volume":"33","author":"Gambi","year":"1983","journal-title":"Curr Ther Res"},{"issue":"12","key":"10.1016\/j.jpainsymman.2004.05.002_BIB82","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1212\/WNL.23.12.1313","article-title":"The effect of dantrolene sodium on spasticity in multiple sclerosis","volume":"23","author":"Gelenberg","year":"1973","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.jpainsymman.2004.05.002_BIB83","first-page":"384","article-title":"Dantrolene sodium in children with spasticity","volume":"55","author":"Haslam","year":"1974","journal-title":"Arch Phys Med Rehab"},{"issue":"6","key":"10.1016\/j.jpainsymman.2004.05.002_BIB84","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/j.1469-8749.1980.tb03742.x","article-title":"Dantrolene sodium suspension in treatment of spastic cerebral palsy","volume":"22","author":"Joynt","year":"1980","journal-title":"Dev Med Child Neurol"},{"issue":"1","key":"10.1016\/j.jpainsymman.2004.05.002_BIB85","first-page":"4","article-title":"Objective assessment of spasticity, strength, and function with early exhibition of dantrolene sodium after cerebrovascular accident: a randomized double-blind study","volume":"73","author":"Katrak","year":"1992","journal-title":"Arch Phys Med Rehab"},{"issue":"3","key":"10.1016\/j.jpainsymman.2004.05.002_BIB86","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1185\/03007998409109576","article-title":"Long-term treatment with dantrolene sodium of stroke patients with spasticity limiting the return of function","volume":"9","author":"Ketel","year":"1984","journal-title":"Curr Med Res Opin"},{"issue":"4","key":"10.1016\/j.jpainsymman.2004.05.002_BIB87","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1600-0404.1982.tb03092.x","article-title":"Dantrolene sodium in chronic spasticity of varying etiology","volume":"65","author":"Luisto","year":"1982","journal-title":"Acta Neurol Scand"},{"issue":"8","key":"10.1016\/j.jpainsymman.2004.05.002_BIB88","first-page":"373","article-title":"Spasticity and the effect of dantrolene sodium","volume":"55","author":"Monster","year":"1974","journal-title":"Arch Phys Med Rehab"},{"issue":"4","key":"10.1016\/j.jpainsymman.2004.05.002_BIB89","first-page":"420","article-title":"Effect of dantrolene sodium on the incidence of seizures in children with spasticity","volume":"5","author":"Nogen","year":"1979","journal-title":"Child Brain"},{"issue":"1","key":"10.1016\/j.jpainsymman.2004.05.002_BIB90","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/milmed\/140.1.26","article-title":"Spasmolytic properties of dantrolene sodium: Clinical evaluation","volume":"140","author":"Sheplan","year":"1975","journal-title":"Mil Med"},{"issue":"10","key":"10.1016\/j.jpainsymman.2004.05.002_BIB91","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1001\/jama.1975.03260100016002","article-title":"Treatment of spasticity in multiple sclerosis with dantrolene","volume":"233","author":"Tolosa","year":"1975","journal-title":"JAMA"},{"issue":"1321","key":"10.1016\/j.jpainsymman.2004.05.002_BIB92","first-page":"123","article-title":"Dantrolene sodium in the treatment of spasticity in chronic spinal cord disease","volume":"221","author":"Weiser","year":"1978","journal-title":"Practitioner"},{"issue":"2","key":"10.1016\/j.jpainsymman.2004.05.002_BIB93","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0022-510X(82)90005-3","article-title":"Antiparetic and antispastic effects induced by tizanidine in patients with spastic paresis","volume":"53","author":"Knutsson","year":"1982","journal-title":"J Neurol Sci"},{"issue":"3 Suppl","key":"10.1016\/j.jpainsymman.2004.05.002_BIB94","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1017\/S0317167100038026","article-title":"Treatment of spasticity with tizanidine in multiple sclerosis","volume":"14","author":"Lapierre","year":"1987","journal-title":"Can J Neurol Sci"},{"issue":"9","key":"10.1016\/j.jpainsymman.2004.05.002_BIB95","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1053\/apmr.2001.25141","article-title":"Prospective assessment of tizanidine for spasticity due to acquired brain injury","volume":"82","author":"Meythaler","year":"2001","journal-title":"Arch Phys Med Rehab"},{"issue":"11 Suppl 9","key":"10.1016\/j.jpainsymman.2004.05.002_BIB96","first-page":"S34","article-title":"Tizanidine treatment of spasticity caused by multiple sclerosis: results of a double-blind, placebo-controlled trial","volume":"44","author":"Smith","year":"1994","journal-title":"Neurology"},{"issue":"11 Suppl 9","key":"10.1016\/j.jpainsymman.2004.05.002_BIB97","first-page":"S70","article-title":"A double-blind, placebo-controlled trial of tizanidine in the treatment of spasticity caused by multiple sclerosis. United Kingdom Tizanidine Trial Group","volume":"44","author":"Anonymous","year":"1994","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.jpainsymman.2004.05.002_BIB98","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1469-8749.1966.tb01839.x","article-title":"Chlorzoxazone (Paraflex) in the treatment of severe spasticity","volume":"8","author":"Losin","year":"1966","journal-title":"Dev Med Child Neurol"},{"issue":"2","key":"10.1016\/j.jpainsymman.2004.05.002_BIB99","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1055\/s-0028-1091806","article-title":"Methocarbamol in the treatment of cerebral palsy in children","volume":"3","author":"Bjerre","year":"1971","journal-title":"Neuropadiatrie"},{"issue":"5","key":"10.1016\/j.jpainsymman.2004.05.002_BIB100","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1136\/jnnp.35.5.599","article-title":"Assessment of cyclobenzaprine in the treatment of spasticity","volume":"35","author":"Ashby","year":"1972","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"11","key":"10.1016\/j.jpainsymman.2004.05.002_BIB101","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1001\/jama.1978.03290110049018","article-title":"Cyclobenzaprine in intractable pain syndromes with muscle spasm","volume":"240","author":"Brown","year":"1978","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.jpainsymman.2004.05.002_BIB102","first-page":"58","article-title":"Cyclobenzaprine hydrochloride effect on skeletal muscle spasm in the lumbar region and neck: two double-blind controlled clinical and laboratory studies","volume":"59","author":"Basmajian","year":"1978","journal-title":"Arch Phys Med Rehab"},{"issue":"1","key":"10.1016\/j.jpainsymman.2004.05.002_BIB103","first-page":"39","article-title":"Evaluation of a new skeletal muscle relaxant in the treatment of lower back pain (A Comparison of DS 103-282 with Chlorzoxazone)","volume":"26","author":"Bragstad","year":"1979","journal-title":"Curr Ther Res Clin Exp"},{"issue":"6","key":"10.1016\/j.jpainsymman.2004.05.002_BIB104","first-page":"917","article-title":"Management of acute musculoskeletal conditions\u2014Thoracolumbar strain or sprain: A double-blind evaluation comparing the efficacy and safety of carisoprodol with cyclobenzaprine hydrochloride","volume":"34","author":"Rollings","year":"1983","journal-title":"Curr Ther Res"},{"key":"10.1016\/j.jpainsymman.2004.05.002_BIB105","first-page":"1","article-title":"Management of acute musculoskelatal conditions","volume":"1","author":"Boyles","year":"1983","journal-title":"Todays Ther Trends"},{"key":"10.1016\/j.jpainsymman.2004.05.002_BIB106","series-title":"Cyclobenzaprine in the treatment of local muscle spasm. Clinical evaluation of Flexeril","author":"Scheiner","year":"1978"},{"key":"10.1016\/j.jpainsymman.2004.05.002_BIB107","series-title":"A comparative study of the effects of cyclobenzaprine, diazepam and placebo in the treatment of acute musculoskeletal conditions of the low back. Clinical evaluation of Flexeril","author":"Aiken","year":"1978"},{"issue":"6","key":"10.1016\/j.jpainsymman.2004.05.002_BIB108","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1177\/030006058100900613","article-title":"Tizanidine (DS 103-282) in the treatment of acute paravertebral muscle spasm: a controlled trial comparing tizanidine and diazepam","volume":"9","author":"Fryda-Kaurimsky","year":"1981","journal-title":"J Int Med Res"},{"issue":"1","key":"10.1016\/j.jpainsymman.2004.05.002_BIB109","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1177\/030006058100900111","article-title":"A new skeletal muscle relaxant (DS 103-282) compared to diazepam in the treatment of muscle spasm of local origin","volume":"9","author":"Hennies","year":"1981","journal-title":"J Int Med Res"},{"issue":"2","key":"10.1016\/j.jpainsymman.2004.05.002_BIB110","first-page":"125","article-title":"Cyclobenzaprine and naproxen versus naproxen alone in the treatment of acute low back pain and muscle spasm","volume":"12","author":"Borenstein","year":"1990","journal-title":"Clin Ther"},{"issue":"1","key":"10.1016\/j.jpainsymman.2004.05.002_BIB111","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1177\/030006058301100109","article-title":"A double-blind comparison in general practice of a combination tablet containing orphenadrine citrate and paracetamol (\u2018Norgesic\u2019) with paracetamol alone","volume":"11","author":"McGuinness","year":"1983","journal-title":"J Int Med Res"},{"issue":"2","key":"10.1016\/j.jpainsymman.2004.05.002_BIB112","first-page":"172","article-title":"Dantrolene sodium in low back pain and cervicobrachialgia treatment: A controlled study","volume":"39","author":"Salvini","year":"1986","journal-title":"Curr Ther Res Clin Exp"},{"issue":"3","key":"10.1016\/j.jpainsymman.2004.05.002_BIB113","first-page":"452","article-title":"The effects of cyclobenzaprine on sleep physiology and symptoms in patients with fibromyalgia","volume":"18","author":"Reynolds","year":"1991","journal-title":"J Rheumatol"},{"issue":"12","key":"10.1016\/j.jpainsymman.2004.05.002_BIB114","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1002\/art.1780311210","article-title":"A comparison of cyclobenzaprine and placebo in the management of fibrositis. A double-blind controlled study","volume":"31","author":"Bennett","year":"1988","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.jpainsymman.2004.05.002_BIB115","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/art.1780370106","article-title":"Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia: A randomized, double-blind clinical trial","volume":"37","author":"Carette","year":"1994","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.jpainsymman.2004.05.002_BIB116","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1526-4610.1992.hed3210509.x","article-title":"Tizanidine in chronic tension-type headache: a placebo controlled double-blind cross-over study","volume":"32","author":"Fogelholm","year":"1992","journal-title":"Headache"},{"issue":"25","key":"10.1016\/j.jpainsymman.2004.05.002_BIB117","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.5694\/j.1326-5377.1972.tb92969.x","article-title":"Cyclobenzaprine in the treatment of chronic tension headache","volume":"2","author":"Lance","year":"1972","journal-title":"Med J Aust"},{"issue":"8","key":"10.1016\/j.jpainsymman.2004.05.002_BIB118","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1046\/j.1526-4610.2000.040008633.x","article-title":"Modified-release formulation of tizanidine in chronic tension-type headache","volume":"40","author":"Murros","year":"2000","journal-title":"Headache"},{"issue":"6","key":"10.1016\/j.jpainsymman.2004.05.002_BIB119","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1046\/j.1526-4610.2002.02122.x","article-title":"Chronic daily headache prophylaxis with tizanidine: a double-blind, placebo-controlled, multicenter outcome study","volume":"42","author":"Saper","year":"2002","journal-title":"Headache"},{"issue":"5","key":"10.1016\/j.jpainsymman.2004.05.002_BIB120","first-page":"833","article-title":"An alternative to quinine in nocturnal leg cramps","volume":"45","author":"Latta","year":"1989","journal-title":"Curr Ther Res Clin Exp"},{"issue":"3","key":"10.1016\/j.jpainsymman.2004.05.002_BIB121","first-page":"233","article-title":"A double-blind comparative study of carisoprodol, propoxyphene, and placebo in the management of low back syndrome","volume":"20","author":"Baratta","year":"1976","journal-title":"Curr Ther Res Clin Exp"},{"issue":"4II","key":"10.1016\/j.jpainsymman.2004.05.002_BIB122","first-page":"557","article-title":"Carisoprodol (Soma) in acute back conditions: a double blind, randomized, placebo controlled study","volume":"20","author":"Cullen","year":"1976","journal-title":"Curr Ther Res Clin Exp"},{"issue":"2","key":"10.1016\/j.jpainsymman.2004.05.002_BIB123","first-page":"7","article-title":"Comparison of carisoprodol, butabarbital, and placebo in treatment of the low back syndrome","volume":"117","author":"Hindle","year":"1972","journal-title":"Calif Med"},{"issue":"2","key":"10.1016\/j.jpainsymman.2004.05.002_BIB124","first-page":"165","article-title":"Soma compound (carisoprodol plus phenacetin and caffeine) in the treatment of acute, painful musculoskeletal conditions","volume":"26","author":"Soyka","year":"1979","journal-title":"Curr Ther Res"},{"key":"10.1016\/j.jpainsymman.2004.05.002_BIB125","series-title":"Cyclobenzaprine in the treatment of acute skeletal muscle spasm of local origin. Clinical evaluation of Flexeril","author":"Aiken","year":"1978"},{"issue":"5","key":"10.1016\/j.jpainsymman.2004.05.002_BIB126","first-page":"646","article-title":"A double-blind study of cyclobenzaprine and placebo in the treatment of acute musculoskeletal conditions of the low back","volume":"32","author":"Baratta","year":"1982","journal-title":"Curr Ther Res"},{"issue":"4","key":"10.1016\/j.jpainsymman.2004.05.002_BIB127","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/00007632-198904000-00019","article-title":"Acute back pain and spasm. A controlled multicenter trial of combined analgesic and antispasm agents","volume":"14","author":"Basmajian","year":"1989","journal-title":"Spine"},{"key":"10.1016\/j.jpainsymman.2004.05.002_BIB128","first-page":"462","article-title":"Cyclobenzaprine in the treatment of skeletal muscle spasm in osteoarthritis of the cervical and lumbar spine","volume":"22","author":"Bercel","year":"1977","journal-title":"Curr Ther Res"},{"key":"10.1016\/j.jpainsymman.2004.05.002_BIB129","series-title":"Evaluation of cyclobenzaprine for skeletal muscle spasm of local origin. Clinical evaluation of Flexeril","author":"Bianchi","year":"1978"},{"key":"10.1016\/j.jpainsymman.2004.05.002_BIB130","first-page":"140","article-title":"A randomized trial of cyclobenzaprine for the treatment of fibromyalgia","volume":"19","author":"Quimby","year":"1989","journal-title":"J Rheumatol Suppl"},{"issue":"10","key":"10.1016\/j.jpainsymman.2004.05.002_BIB131","first-page":"44","article-title":"Multiclinic study of a muscle relaxant for treatment of acute musculoskeletal disorders","volume":"8","author":"Steingard","year":"1980","journal-title":"Osteopath Ann"},{"issue":"2","key":"10.1016\/j.jpainsymman.2004.05.002_BIB132","first-page":"85","article-title":"A controlled clinical trial of chlormezanone, orphenadrine, orphenadrine\/paracetamol and placebo in the treatment of painful skeletal muscle spasms","volume":"7","author":"Valtonen","year":"1975","journal-title":"Ann Clin Res"},{"issue":"3","key":"10.1016\/j.jpainsymman.2004.05.002_BIB133","article-title":"A study of metaxalone (Skelaxin) vs. placebo in acute musculoskeletal disorders: a cooperative study","volume":"18","author":"Dent","year":"1975","journal-title":"Curr Ther Res. Clin Exp"},{"issue":"11","key":"10.1016\/j.jpainsymman.2004.05.002_BIB134","first-page":"677","article-title":"A second look at a skeletal muscle relaxant: A double-blind study of metaxalone","volume":"6","author":"Fathie","year":"1964","journal-title":"Curr Ther Res"},{"issue":"6","key":"10.1016\/j.jpainsymman.2004.05.002_BIB135","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1001\/jama.1966.03100060119031","article-title":"Double-blind study of metaxalone; use as skeletal-muscle relaxant","volume":"195","author":"Diamond","year":"1966","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.jpainsymman.2004.05.002_BIB136","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1177\/030006058801600201","article-title":"A multicentre placebo-controlled study in general practice to evaluate the efficacy and safety of tizanidine in acute low-back pain","volume":"16","author":"Berry","year":"1988","journal-title":"J Int Med Res"},{"issue":"2","key":"10.1016\/j.jpainsymman.2004.05.002_BIB137","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/030006058801600202","article-title":"Tizanidine and ibuprofen in acute low-back pain: results of a double-blind multicentre study in general practice","volume":"16","author":"Berry","year":"1988","journal-title":"J Int Med Res"},{"issue":"4","key":"10.1016\/j.jpainsymman.2004.05.002_BIB138","first-page":"454","article-title":"A comparative trial of DS 103-282 and placebo in the treatment of acute skeletal muscle spasms due to disorders of the back","volume":"26","author":"Lepisto","year":"1979","journal-title":"Curr Ther Res"},{"issue":"1","key":"10.1016\/j.jpainsymman.2004.05.002_BIB139","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0011-393X(98)85019-4","article-title":"Efficacy and gastroprotective effects of tizanidine plus diclofenac versus placebo plus diclofenac in patients with painful muscle spasms","volume":"59","author":"Anonymous","year":"1998","journal-title":"Curr Ther Res"},{"issue":"4","key":"10.1016\/j.jpainsymman.2004.05.002_BIB140","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/00007632-198505000-00010","article-title":"Baclofen for the treatment of acute low-back syndrome. A double-blind comparison with placebo","volume":"10","author":"Dapas","year":"1985","journal-title":"Spine"},{"issue":"6","key":"10.1016\/j.jpainsymman.2004.05.002_BIB141","first-page":"525","article-title":"A controlled study of methocarbamol (Robaxin) in acute painful musculoskeletal conditions","volume":"17","author":"Tisdale","year":"1975","journal-title":"Curr Ther Res Clin Exp"},{"issue":"2","key":"10.1016\/j.jpainsymman.2004.05.002_BIB142","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/00002508-198806000-00004","article-title":"Acute low back pain. Symptomatic treatment with a muscle relaxant drug","volume":"4","author":"Casale","year":"1988","journal-title":"Clin J Pain"},{"key":"10.1016\/j.jpainsymman.2004.05.002_BIB143","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0016-5085(77)80141-8","article-title":"Dantrolene-associated hepatic injury: incidence and character","volume":"72","author":"Utili","year":"1977","journal-title":"Gastroenterol"},{"key":"10.1016\/j.jpainsymman.2004.05.002_BIB144","unstructured":"FDA. Accessed June 7, 2004. http:\/\/www.fda. gov\/cder\/foi\/label\/2002\/21447lbl.pdf - Cached -. FDA. Available: 8\/30\/2002"},{"key":"10.1016\/j.jpainsymman.2004.05.002_BIB145","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S0168-8278(96)80252-2","article-title":"A case of tizanidine-induced hepatic injury","volume":"25","author":"de Graaf","year":"1996","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.jpainsymman.2004.05.002_BIB146","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0022-5347(17)35930-X","article-title":"Neurological manifestations of baclofen withdrawal","volume":"150","author":"Rivas","year":"1993","journal-title":"J Urol"},{"issue":"3 Pt 1","key":"10.1016\/j.jpainsymman.2004.05.002_BIB147","first-page":"697","article-title":"Prolonged seizure activity after baclofen withdrawal","volume":"42","author":"Kofler","year":"1992","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.jpainsymman.2004.05.002_BIB148","first-page":"304","article-title":"Adverse effects secondary to baclofen withdrawal","volume":"19","author":"Garabedian-Ruffalo","year":"1985","journal-title":"Drug Intel Clin Pharm"},{"issue":"5","key":"10.1016\/j.jpainsymman.2004.05.002_BIB149","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1176\/ajp.141.5.692","article-title":"Dyskinesia and psychosis in a patient following baclofen withdrawal","volume":"141","author":"Kirubakaran","year":"1984","journal-title":"Am J Psychiatry"},{"issue":"1","key":"10.1016\/j.jpainsymman.2004.05.002_BIB150","first-page":"96","article-title":"Hyperthermia associated with baclofen withdrawal and increased spasticity","volume":"74","author":"Mandac","year":"1993","journal-title":"Arch Phys Med Rehab"},{"issue":"11","key":"10.1016\/j.jpainsymman.2004.05.002_BIB151","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1177\/106002809703101108","article-title":"Baclofen toxicity in patients with severely impaired renal function","volume":"31","author":"Chen","year":"1997","journal-title":"Ann Pharmacother"},{"issue":"662","key":"10.1016\/j.jpainsymman.2004.05.002_BIB152","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1136\/pgmj.56.662.865","article-title":"Complications of baclofen overdosage","volume":"56","author":"Ghose","year":"1980","journal-title":"Postgrad Med J"},{"issue":"652","key":"10.1016\/j.jpainsymman.2004.05.002_BIB153","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1136\/pgmj.56.652.108","article-title":"Baclofen overdose","volume":"56","author":"Lipscomb","year":"1980","journal-title":"Postgrad Med J"},{"issue":"1","key":"10.1016\/j.jpainsymman.2004.05.002_BIB154","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/ana.410360122","article-title":"Baclofen-induced generalized nonconvulsive status epilepticus","volume":"36","author":"Zak","year":"1994","journal-title":"Ann Neurol"},{"issue":"4","key":"10.1016\/j.jpainsymman.2004.05.002_BIB155","first-page":"1223","article-title":"Abuse of skeletal muscle relaxants","volume":"44","author":"Elder","year":"1991","journal-title":"Am Fam Physician"},{"issue":"3","key":"10.1016\/j.jpainsymman.2004.05.002_BIB156","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0379-0738(97)02128-2","article-title":"Meprobamate overdosage: a continuing problem. Sensitive GC-MS quantitation after solid phase extraction in 19 fatal cases","volume":"86","author":"Gaillard","year":"1997","journal-title":"Forensic Sci Int"},{"issue":"6 I","key":"10.1016\/j.jpainsymman.2004.05.002_BIB157","first-page":"894","article-title":"Cyclobenzaprine (Flexeril(TM)): Report of a postmarketing surveillance program","volume":"28","author":"Nibbelink","year":"1980","journal-title":"Curr Ther Res Clin Exp"},{"key":"10.1016\/j.jpainsymman.2004.05.002_BIB158","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1001\/archinte.1986.00360180197029","article-title":"Chlorzoxazone hepatotoxic reactions","volume":"146","author":"Powers","year":"1986","journal-title":"Arch Intern Med"},{"issue":"5","key":"10.1016\/j.jpainsymman.2004.05.002_BIB159","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1191\/026921599677595404","article-title":"A review of the properties and limitations of the Ashworth and modified Ashworth Scales as measures of spasticity","volume":"13","author":"Pandyan","year":"1999","journal-title":"Clin Rehabil"},{"issue":"12","key":"10.1016\/j.jpainsymman.2004.05.002_BIB160","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1212\/WNL.45.12.2295","article-title":"Tizanidine and spasticity","volume":"45","author":"Landau","year":"1995","journal-title":"Neurol"}],"container-title":["Journal of Pain and Symptom Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392404002155?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392404002155?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:54:42Z","timestamp":1760129682000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0885392404002155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":160,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["S0885392404002155"],"URL":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2004.05.002","relation":{},"ISSN":["0885-3924"],"issn-type":[{"value":"0885-3924","type":"print"}],"subject":[],"published":{"date-parts":[[2004,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative efficacy and safety of skeletal muscle relaxants for spasticity and musculoskeletal conditions: a systematic review","name":"articletitle","label":"Article Title"},{"value":"Journal of Pain and Symptom Management","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2004.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 U.S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}